Journey Medical Corporation — Form 8-K Summary
Business context and reporting period
Journey Medical Corporation furnished a Form 8-K dated March 29, 2023, under Item 2.02 to announce a corporate update and financial results for the three months and full year ended December 31, 2022. The filing references a related press release furnished as Exhibit 99.1.
Financial results and liquidity
The provided filing text does not include clear values for revenue, net income or loss, cash flow, margins, debt, cash, liquidity, or other financial metrics. Those details may be contained in Exhibit 99.1, which is referenced but not included in the supplied text.
Material changes versus the prior comparable period
The filing text does not provide quantitative or qualitative comparisons with the prior-year periods.
Guidance, outlook, risks, and unusual items
The filing states that the company issued a corporate update, but it does not provide the content of management’s commentary, guidance, outlook, risks, contingencies, or unusual items.
Important facts to verify
- Review Exhibit 99.1 for the complete fourth-quarter and full-year 2022 financial results.
- Verify reported revenue, profitability, cash flow, cash balance, debt, liquidity, and operating margins.
- Review management’s corporate update, guidance, business developments, and identified risks.
- Note that the information and Exhibit 99.1 were furnished, not filed, for purposes of Section 18 of the Exchange Act and are not incorporated by reference except where expressly stated.
- The company is listed on the Nasdaq Capital Market under the symbol DERM and identified as an emerging growth company.